Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access June 1, 2011

Prevalence of nephrolithiasis in polycystic kidney disease

Alma Idrizi EMAIL logo , Myftar Barbullushi , Margarita Gjata , Alketa Koroshi , Enver Roshi , Teuta Backa , Sulejman Kodra and Nestor Thereska
From the journal Open Medicine

Abstract

We aim to define the prevalence of nephrolithiasis, the impact of anatomic and metabolic factors to stone formation and prognosis of patients with autosomal dominant polycystic kidney disease in Albania. We included 200 patients with autosomal dominant polycystic kidney from 2002 to 2009. The patients underwent X-ray, renal ultrasonography. We performed the metabolic evaluation of blood and urine. Survival times were calculated as the time to dialysis, transplantation, or death. Kaplan-Meier product-limit survival curves were constructed. Log rank test was used to compare the survival curves. Nephrolithiasis was present in 116 of our patients with autosomal dominant polycystic kidney disease (58%), with a mean age 46.4±5.7 years. Sixty five patients with kidney stones (56%) were women. The stones were composed primarily of urate (47%) and calcium oxalate (39%), and other compounds 14%. In 40% of patients the presence of stones was associated with a history of urinary tract infections and flank pain. In our study the prevalence of nephrolithiasis is 58%, higher than it reported in literature. Except anatomic and metabolic factors, there are other contributor factors to stone formation in our patients such socioeconomic status of patients, geographic zones and dietary habits.

[1] Wilson PD, Goilav B. Cystic disease of the kidney. Annu Rev Pathol Mech Dis 2: 341–368, 2007 http://dx.doi.org/10.1146/annurev.pathol.2.010506.09185010.1146/annurev.pathol.2.010506.091850Search in Google Scholar

[2] Simon HB, Thompson GJ. Congenital renal polycystic disease. JAMA 159: 657–662, 1955 10.1001/jama.1955.02960240023006Search in Google Scholar

[3] Milutinovic J, Fialkow PJ, Agodoa LY et al. Autosomal dominant polycystic kidney disease: Symptoms and clinical findings. Q J Med 212: 511–522, 1984 Search in Google Scholar

[4] Delaney VB, Adler S, Bruns FJ et al. Autosomal dominant polycystic kidney disease: Presentation, complications and prognosis. Am J Kidney Dis 5: 104–111, 1985 Search in Google Scholar

[5] Torres WE, Wilson DM, Hattery RR, Segura JW. Renal stones disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 22: 513–519, 1993 10.1016/S0272-6386(12)80922-XSearch in Google Scholar

[6] Levine E, Grantham JJ. Calcified renal stones and cyst calcification in autosomal dominant polycystic kidney disease: Clinical and CT study in 84 patients. Am J Roentgenol 159: 77–81, 1992 Search in Google Scholar

[7] Dalgaard OZ. Bilateral polycystic disease of the kidneys: a follow-up of two hundred and eighty four patients and their families. Acta Med Scand 328(S): 255–256, 1957 Search in Google Scholar

[8] Segal AJ, Spataro RF, Barbaric ZL. Adult polycystic kidney disease: a review of 100 cases. J Urol 118: 711–713, 1967 Search in Google Scholar

[9] Gambaro G, Fabris A, Puliatta D, Lupo A. Lithiasis in cystic kidney disease and malformations of the urinary tract. Urol Res 34: 102–107, 2006 http://dx.doi.org/10.1007/s00240-005-0019-z10.1007/s00240-005-0019-zSearch in Google Scholar

[10] Torres WE, Erickson SB, Smith LH, Wilson DM et al. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis 11: 318–325, 1988 10.1016/S0272-6386(88)80137-9Search in Google Scholar

[11] Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease. Lancet 2: 824–827, 1994 http://dx.doi.org/10.1016/S0140-6736(94)92026-510.1016/S0140-6736(94)92026-5Search in Google Scholar

[12] Sallée M, Rafat C, Zahar JR, Paulmier B, Grünfeld JP, Knebelmann B, Fakhouri F. Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol 4: 1183–1189, 2009 http://dx.doi.org/10.2215/CJN.0187030910.2215/CJN.01870309Search in Google Scholar

[13] Levy FL, Adams-Huet B, Pak CYC: Ambulatory evaluation of nephrolithiasis: An update from 1980. Am J Med 98: 50–59, 1995 http://dx.doi.org/10.1016/S0002-9343(99)80080-110.1016/S0002-9343(99)80080-1Search in Google Scholar

[14] Heilberg IP, Boim MA, Schor N. Biochemical differences between stone formers and normal subjects. In: Stone Disease: 1st International Consultation on Stone Disease, 21st Ed., edited by Segura J, Conort P, Khoury S, Pak C, Preminger GM, Tolley D, France, Health Publications 61–64, 2003 Search in Google Scholar

[15] Statisical Analysis System, Cary, NC, SAS Institute Inc 1996 Search in Google Scholar

[16] Cox DR: Regression models and life tables. J R Stat Soc B34: 187–220, 1972 10.1111/j.2517-6161.1972.tb00899.xSearch in Google Scholar

[17] Grampsas SA, Chandhoke PS, Fan J et al. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 36(1): 53–57, 2000 http://dx.doi.org/10.1053/ajkd.2000.826610.1053/ajkd.2000.8266Search in Google Scholar PubMed

[18] Torres VE, Harris C, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 369: 1287–1301, 2007 http://dx.doi.org/10.1016/S0140-6736(07)60601-110.1016/S0140-6736(07)60601-1Search in Google Scholar

[19] Nishiura JL, Neves RFCA, Eloi SRM, Cintra SMLF, Ajzen SA, Heilberg IP. Evaluation of Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease Patients. Clin J Am Soc Nephrol 4: 838–844, 2009 http://dx.doi.org/10.2215/CJN.0310060810.2215/CJN.03100608Search in Google Scholar

[20] Jackman SV, Potter SR, Regan F, Jarrett TW. Plain abdominal x-ray versus computerized tomography screening: sensitivity for stone localization after nonenhanced spiral computerized tomography. J Urol 164(2): 308–310, 2000 http://dx.doi.org/10.1016/S0022-5347(05)67346-610.1016/S0022-5347(05)67346-6Search in Google Scholar

[21] Gabow PA, Duley I, Johnson AM. Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am J Kidney Dis 20: 140–143, 1992 10.1016/S0272-6386(12)80541-5Search in Google Scholar

[22] Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41: 1311–1319, 1992 http://dx.doi.org/10.1038/ki.1992.19510.1038/ki.1992.195Search in Google Scholar PubMed

[23] Johnson AM, Gabow PA: Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol 8: 1560–1567, 1997 10.1681/ASN.V8101560Search in Google Scholar PubMed

Published Online: 2011-6-1
Published in Print: 2011-8-1

© 2011 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 28.11.2022 from frontend.live.degruyter.dgbricks.com/document/doi/10.2478/s11536-011-0043-z/html
Scroll Up Arrow